Can a patient stop taking sertraline (selective serotonin reuptake inhibitor) after one week of taking it?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 30, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Can a Patient Stop Sertraline After One Week?

Yes, a patient can safely stop sertraline after only one week of use without requiring a gradual taper, as discontinuation syndrome risk is minimal with such short-term exposure.

Rationale for Safe Discontinuation

After just one week of sertraline treatment, the risk of discontinuation syndrome is extremely low because:

  • Discontinuation symptoms are primarily associated with longer-term use - The FDA label and clinical guidelines emphasize that withdrawal symptoms occur when stopping sertraline after extended treatment, not after brief exposure 1
  • Steady-state concentrations are not yet achieved - Sertraline reaches steady state after approximately 7 days, meaning the patient has barely reached therapeutic drug levels 2, 3
  • Minimal physiological adaptation has occurred - One week is insufficient time for significant neuroadaptation to develop that would necessitate gradual dose reduction 4

Evidence Supporting Brief Exposure Safety

The American Academy of Child and Adolescent Psychiatry guidelines specify that:

  • Minimum taper duration of 2-4 weeks applies only to short-term therapy (defined as longer than one week but not long-term), while patients on therapy for less than this duration can typically discontinue more abruptly 4
  • Sertraline has been associated with discontinuation syndrome characterized by dizziness, fatigue, myalgias, headaches, nausea, insomnia, and sensory disturbances - but these symptoms emerge primarily after extended use, not after one week 4, 1

Important Caveats

While abrupt discontinuation is generally safe after one week, the patient should still:

  • Monitor for mild transient symptoms such as headache, nausea, or dizziness in the 24-48 hours following discontinuation, though these are unlikely 1
  • Contact their healthcare provider if any concerning symptoms develop, particularly mood changes or anxiety 1
  • Understand the reason for discontinuation - if stopping due to side effects versus lack of efficacy versus other reasons, as this may inform future treatment decisions 4

Clinical Context

It's worth noting that:

  • Therapeutic response typically requires 2-6 weeks of treatment, with maximal improvement by week 12, so one week is insufficient to assess efficacy 4
  • Most adverse effects emerge within the first few weeks, so stopping at one week may be due to early side effects that often resolve with continued treatment 4, 5
  • The patient has not yet experienced the full therapeutic potential of sertraline, which may be relevant if the medication was prescribed for depression, anxiety, OCD, panic disorder, PTSD, or PMDD 1, 6, 7

References

Research

Clinical pharmacokinetics of sertraline.

Clinical pharmacokinetics, 2002

Research

Clinical implications of the pharmacology of sertraline.

International clinical psychopharmacology, 1991

Guideline

Sertraline Dosing and Administration

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Toleration and safety of sertraline: experience worldwide.

International clinical psychopharmacology, 1991

Research

Sertraline in the treatment of panic disorder.

Drugs of today (Barcelona, Spain : 1998), 2009

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.